gemcitabine-oxaliplatin regimen

Known as: GEM-OX Regimen, GEMOX Regimen 
A regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
02420042016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
PURPOSE Our aim was to investigate the hypothesis that the CT perfusion (CTP) is a more sensitive image biomarker when compared… (More)
Is this relevant?
2010
2010
BACKGROUNDS The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma… (More)
Is this relevant?
2009
2009
Chemotherapy represents a palliative treatment, with poor response rates and a median survival of less than 6 months in patients… (More)
  • figure 2
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
4520 Background: There is no standard regimen for palliative chemotherapy of advanced biliary cancers. The GEMOX regimen is an… (More)
Is this relevant?
2008
2008
The aim of this study was to evaluate the safety and activity of a gemcitabine-oxaliplatin combination (GEMOX) regimen in… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND New systemic therapies are needed to improve the prognosis of patients with advanced-stage hepatocellular carcinoma… (More)
Is this relevant?
2006
2006
Gemcitabine and oxaliplatin (GEMOX) are active as first-line therapy against advanced pancreatic cancer. This study aims to… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
PURPOSE To evaluate the activity and tolerance of gemcitabine in combination with oxaliplatin (GEMOX regimen) in pretreated… (More)
Is this relevant?
2006
2006
PURPOSE To evaluate the efficacy and tolerance of the gemcitabine/oxaliplatin (GEMOX) combination as second-line chemotherapy for… (More)
Is this relevant?
2004
2004
6592 Background: High-dose therapy with autologous stem cell support (HDT) is now an established treatment for chemosensitive… (More)
Is this relevant?